Stage
01
Inquiry
Tell us about your condition. Speak with our medical advisors — no obligation.
Stem Cell Treatment
Motor Neuron Diseases
Mesenchymal stem cells used to slow ALS and PLS progression — addressing the inflammation in the central nervous system, not just the symptoms. Patient stories inside.
What Makes our Treatment for Motor Neuron Diseases (MND) Effective?
Since 2005, we have been developing comprehensive stem cell treatment protocols for Motor Neuron Diseases (MND) such as Primary Lateral Sclerosis (PLS) and Amyotrophic Lateral Sclerosis (ALS) to overcome the limitations of conventional therapies. In our protocols, stem cells are combined with specialized therapies for motor neuron diseases that not only focus on helping the patient to cope with their symptoms, but also treat the direct cause of the loss of function by promoting healing of the damaged nerves and promote muscle growth. We believe that our comprehensive treatment approach for MND gives our patients the best chances of improvements, allowing for a better quality of life.
How can mesenchymal stem cells help patients with MND?
The mesenchymal stem cells used for treatment have the ability to differentiate into a variety of cell types and can migrate to damaged tissues to promote repair and regeneration. They also have immunomodulatory properties, which can help reduce inflammation in the central nervous system, a hallmark of many neurodegenerative diseases. Several preclinical and clinical studies have shown promising results using mesenchymal stem cells to treat neurodegenerative diseases.
FREE CONSULTATION
Contact one of our specialists and get more information
Mia Ruthey was diagnosed with Primary Lateral Sclerosis (PLS) which is a motor neuron disease similar to Amyotrophic Lateral Sclerosis (ALS) / Lou Gehrig’s disease. Without hope from Western medicine, Mia found Beike and stem cell treatment. Today, her strength ad endurance have improved and increased her quality of life beyond expectation.
Watch more videosPotential improvements after stem cell treatment for Motor Neuron Disease
The purpose of the treatment for MNDs is to promote repair of the neurological damage and regulate the immune system. Various kinds of improvement are possible after our treatment and our past patients have experienced the following*:
Outcome data is temporarily unavailable.
Our Treatment Program in Details
Our stem cell transplantation program for motor neuron diseases (e.g. PLS, ALS) consist in 3 to 8 simple and minimally invasive injections of umbilical cord derived stem cells. The stem cells are transplanted using two separate methods: by intravenous way using a standard IV drip system, and through intrathecal injection performed after lumbar puncture. These two delivery methods allow for increased efficacy while ensuring safety and minimum inconvenience for the patient. Read more about each procedure below:
01 10 to 23 Days Stay
02 IV & Intrathecal Injections
03 UCBSC / UCMSC Cells
04 Daily Therapy Program
05 120-280 Million Cells
06 Nutrition Program
Continue reading
Related stories & articles
Find out more about patients previously treated with Beike stem cell protocols. The families participating in these blog posts talk about their stories and present their own view of the treatment, including thoughts regarding the daily therapies, the stem cell injection themselves as well as improvement noticed during and after treatment.
How it works
A clear path forward
From your first inquiry to post-treatment follow-up —
we guide you every step of the way.
Stage
02
Evaluation
Our doctors review your medical records and recommend a tailored protocol.
Stage
03
Treatment
Receive specialized stem cell therapy at our partner hospital, fully supervised.
Stage
04
Follow-up
We stay in touch and monitor your progress for the months that follow.
Free consultation
Speak with a medical advisor
No obligation. We’ll review your situation and respond within 48 hours.
- Response within 48 hours from a medical advisor.
- Confidential — your information stays with our medical team.
- No cost, no obligation. We review your case and respond.
Reviewed by the Beike medical advisory team — answering patient inquiries since 2005.
